Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy
- 20 November 2023
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 39 (2) , 380-390
Abstract
Background: Mixed pathology is common at autopsy for a number of age‐associated neurodegenerative disorders; however, the frequency of comorbid pathologies in multiple system atrophy (MSA) and their clinical correlations are poorly understood.Objective: We determined the frequency of comorbid pathologic processes in autopsy‐confirmed MSA and assessed their clinical correlates.Methods: This study included 160 neuropathologically established MSA from the Mayo Clinic brain bank. Clinical information, including age at onset or death, clinical subtype, initial symptoms, antemortem clinical diagnosis, and cognitive dysfunction was collected. We assessed comorbid pathologies including Alzheimer's disease neuropathologic change, Lewy‐related pathology, argyrophilic grain disease, age‐related τ astrogliopathy, transactive DNA‐binding protein 43 pathology, cerebral amyloid angiopathy, and cerebrovascular small vessel disease and examined their clinical impact.Results: The majority of MSA patients (62%) had no significant comorbid pathologies. There was a positive correlation between age at onset or death with the number of comorbid pathologies; however, even in the highest quartile group (average age at death 78 ± 6 years), the average number of comorbid pathologies was <2. Logistic regression analysis revealed that none of the assessed variables, including sex, age at onset, and the presence or absence of each comorbid pathology, were significantly associated with cognitive dysfunction.Conclusions: The majority of MSA patients do not have comorbid pathologies, even in advanced age, indicating that MSA is unique among neurodegenerative disorders in this regard. There was minimal clinical impact of comorbid pathologies in MSA. These findings warrant focusing on α‐synuclein for the treatment strategy for MSA. © 2023 International Parkinson and Movement Disorder Society.Keywords
Funding Information
- American Parkinson Disease Association (N/A)
- CurePSP
- Multiple System Atrophy Coalition
- Uehara Memorial Foundation
This publication has 47 references indexed in Scilit:
- Parkinson's Disease and Parkinsonism: NeuropathologyCold Spring Harbor Perspectives in Medicine, 2012
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-SynucleinCell, 2012
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- In vivo demonstration that α-synuclein oligomers are toxicProceedings of the National Academy of Sciences, 2011
- Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate?Neuroscience Letters, 2009
- Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophyNeuropathology and Applied Neurobiology, 2007
- Phases of Aβ-deposition in the human brain and its relevance for the development of ADNeurology, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)Journal of the Neurological Sciences, 1989